Newly published research from a National Cancer Institute-funded randomized trial shows that women who were taught skills to manage stress early in their breast cancer treatment had improved survival rates and longer intervals of remission 8 to 15 years post-diagnosis.
News : 2015
Using “big data” sets and powerful computational screening tools, researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have identified a compound that inhibits two different cellular targets in cancer. Their findings were recently published in Scientific Reports.
A study conducted by child and adolescent psychiatrists with UHealth – the University of Miami Health System has shown that young people in South Florida who were admitted into inpatient psychiatric care for depression, anxiety and other mental health issues also suffered from significant rates of cyberbullying.
In an effort to bring awareness to the approximately 61.5 million Americans who experience some form of mental illness each year, a first-of-its-kind gala was held recently to benefit the University of Miami Miller School of Medicine Department of Psychiatry and Behavioral Sciences. The inaugural Shatter the Stigma gala was held October 8 to support the department’s research and programs.
The National Institutes of Health has awarded the research team of Claes Wahlestedt, M.D., Ph.D., Associate Dean and Director of the Center for Therapeutic Innovation at the Miller School of Medicine, a $1.725 million, five-year grant to study epigenetic mechanisms that underlie alcoholism. The research could lead to new treatments for this prevalent and debilitating disorder.
A record number of University of Miami and Miller School of Medicine students and employees came together recently for the Out of the Darkness Walk, sponsored by the American Foundation for Suicide Prevention. Walkers joined to remember friends, family members, and colleagues they had lost, and to help strengthen efforts to prevent suicide.
University of Miami Miller School of Medicine psychiatrist Charles B. Nemeroff, M.D., Ph.D., was honored by the International Society of Psychoneuroendocrinology (ISPNE) with its 2015 Lifetime Achievement Award for his research into the biological basis of depression and other neuropsychiatric disorders.
Sara J. Czaja, Ph.D., Leonard M. Miller Professor of Psychiatry and Behavioral Sciences, and Scientific Director of the Center on Aging, was honored recently by the American Psychological Association (APA) for her numerous contributions to the field of applied gerontology.
A new University of Miami study, aimed at identifying early signs of Alzheimer’s disease and other neurocognitive decline among Latinos and Hispanics, could help delay or even prevent its onset thanks to a $5.67 million, five-year grant from the National Institute on Aging.
Please join Team UHealth, in partnership with the American Foundation for Suicide Prevention, in the annual Out of the Darkness Walk to raise money and awareness to help prevent suicide. The walk takes place on Sunday, October 11, from 10 a.m. to noon, beginning at the Stanford Rock on the Coral Gables campus.
Philip D. Harvey, Ph.D., professor of psychiatry and behavioral sciences, has been included in Thomson Reuters’ Highly Cited Researchers 2014, which recognizes scientists whose published works are most cited by fellow researchers. The publication gave Harvey the “mark of exceptional impact.”
Sara J. Czaja, Ph.D., Leonard M. Miller Professor of Psychiatry and Behavioral Sciences, and Scientific Director of the Center on Aging, has been awarded a five-year grant of $7.8 million by the National Institute on Aging to fund the fourth research phase of the Center for Research and Education on Aging and Technology Enhancement (CREATE IV), a PO1 NIH center grant.
A team of researchers at the Sylvester Comprehensive Cancer Center and the Miller School of Medicine has discovered that a previously unappreciated so-called long noncoding RNA mechanism controls tumor growth of Glioblastoma Multiforme cells.
The University of Miami Hospital and Clinics welcomed all 189 third-year Miller School students from both the Miami and regional medical campuses June 6-7 for the 20th annual Objective Structured Clinical Examinations, a medical school rite of passage that tests the clinical skills of students. More than 100 faculty members served as evaluators for the annual assessment.
Dean Pascal J. Goldschmidt, M.D., was honored with the Education/Advocacy Award at the 2015 United HomeCare Annual Dinner on May 14. The award is one of the Claude Pepper Awards — named for the late U.S. Senator from Florida who fought for the rights and the welfare of the elderly and the poor — given out at the dinner each year to celebrate the achievements of exceptional individuals who exemplify Pepper’s spirit and ideals.
University of Miami Hospital and the Department of Psychiatry and Behavioral Sciences, along with the National Alliance on Mental Illness (NAMI), were host to “STOP the Stigma: A Mental Health Summit.” The event was designed to educate the public and professionals on the latest research, diagnoses, intervention and best practices to optimize recovery.
Surrounded by colleagues and staff at the Miami VA, Philip D. Harvey, Ph.D., was presented the John Blair Barnwell Award on Monday by Theresa Gleason, Ph.D., the VA’s Acting Deputy Chief Research and Development Officer. Gleason, who was visiting from Washington, noted that it is the highest honor for scientific achievement presented by her department and the first time the award has gone to a psychologist.
Charles B. Nemeroff, M.D., Ph.D., Leonard M. Miller Professor and Chairman of the Department of Psychiatry and Behavioral Sciences, and Director of the Center on Aging, has been awarded the title of Doctor Honoris Causa by the University Maimonides in Buenos Aires, Argentina.
Miller School of Medicine researchers, collaborating with investigators at three other institutions, have found a link between certain protein inhibitors and the reduction in growth of medulloblastoma, the most common malignant pediatric brain tumor. Their findings may lead to treatments for other cancers, as well as a variety of other diseases and types of neurological injuries.
Charles Nemeroff, M.D., Ph.D., professor and Chairman of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine, and Spencer Eth, M.D., professor and Director of the Forensic Psychiatry Fellowship and Chief of Mental Health, joined members of Prosecutors Against Gun Violence (PAGV) last Tuesday for a summit that focused on management of mental illness and gun violence.
In honor of National Mental Health Awareness Month this May, the National Alliance on Mental Illness (NAMI) and the University of Miami Miller School of Medicine will host “STOP the Stigma: A Mental Health Summit” on Saturday, May 2, from 8 a.m. to 4:30 p.m. at University of Miami Hospital’s Seminar Center.
The Hispanic Community Health Study/Study of Latinos (HCHS/SOL), in collaboration with the National Hispanic Council on Aging (NHCOA), trained 27 committed individuals from across South Florida on community advocacy tools during a two-day Empowerment and Civic Engagement Training (ECET) seminar held at the Miller School of Medicine on March 10-11.
Philip D. Harvey, Ph.D., Leonard M. Miller Professor of Psychiatry and Behavioral Sciences, made a presentation at an International Conference on Memory in the Diseased Brain held at Vatican City. The gathering of international memory experts was held under the auspices of the Pontifical Academy of Sciences and was focused on examining what occurs when memory fails as part of aging and in severe psychiatric disorders.
The University of Miami Miller School of Medicine has been awarded more than $900,000 in grant awards from the Florida Department of Health to be used for projects supporting research leading to the prevention or cure of Alzheimer’s disease.
A team of Miller School scientists has identified a compound that, when targeted to a location on the Hedgehog molecular signaling pathway, may prevent the recurrence of medulloblastoma, a type of brain tumor prevalent in children and adults.